{
  "trial_id": "NCT00645385",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "met",
      "evidence": "41 year man"
    },
    {
      "criterion": "Histologic diagnosis of high grade malignant glioma",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Solitary, supratentorial lesions that do not cross the midline",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Karnofsky performance status >=60%",
      "label": "met",
      "evidence": "normal otherwise"
    },
    {
      "criterion": "Expected survival of > three months",
      "label": "met",
      "evidence": "physical exam and lab studies were normal"
    },
    {
      "criterion": "Adequate hematologic reserve with WBC>=3000/mm3, absolute neutrophils >=1500/mm3 and platelets >=100,000/ mm3",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Pre-enrollment chemistry parameters must show: bilirubin<1.5X the institutional upper limit of normal (IUNL); AST or ALT<2.5X IUNL and creatinine<1.5X IUNL",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Patients must agree to use a medically effective method of contraception during and for a period of three months after the treatment period",
      "label": "met",
      "evidence": "use condom during the intercourse"
    },
    {
      "criterion": "Patients must be able to understand and give written informed consent",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Known hypersensitivity or allergy to BCNU (carmustine) or other components of the Gliadel wafer, such as polifeprosan polymer",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Multifocal CNS disease",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Diagnosis of prior CNS tumor",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Women who are pregnant or lactating",
      "label": "not_met",
      "evidence": "He is in relation with several partners"
    },
    {
      "criterion": "Posterior Fossa or Brain stem tumor",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Open communication of the resection cavity with the ventricular system and tumors that cross the midline",
      "label": "not_met",
      "evidence": "The dorsum and sole of the foot was unaffected"
    },
    {
      "criterion": "Concurrent severe medical (e.g., active infection, acute hepatitis, cardiac arrhythmia, unstable angina, congestive heart failure, uncontrolled diabetes mellitus, uncontrolled seizures, pulmonary insufficiency, pulmonary fibrosis, pulmonary embolus, etc) or psychiatric illness",
      "label": "not_met",
      "evidence": "His physical exam and lab studies were normal otherwise"
    },
    {
      "criterion": "Patients with significant intercurrent medical or psychiatric conditions that would place them at increased risk or affect their ability to receive or comply with treatment or post-treatment clinical monitoring",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has a confirmed diagnosis of Tinea pedis infection, but meets most inclusion criteria and does not have any exclusion criteria that would make them likely ineligible.",
  "_meta": {
    "topic_id": "48",
    "trial_id": "NCT00645385",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}